JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us
Esta página ha sido traducida por una máquina. Otras páginas pueden seguir apareciendo en inglés. View in English

La hemocromatosis

  • 0Department of Medicine, Schulich School of Medicine & Dentistry, Western University, London, ON, Canada.
Lancet +

|

30 de abril de 2023

|

30 de abril de 2023

Ver abstracta en PubMed

Resumen

Este resumen es generado por máquina.

La hemocromatosis, un trastorno genético común, a menudo es mal diagnosticada. Las pruebas genéticas tempranas y el tratamiento de flebotomía pueden prevenir complicaciones graves como enfermedad hepática y muerte.

Área De La Ciencia

  • La genética médica
  • Hepatología
  • Médico interno

Sus Antecedentes

  • La hemocromatosis es un trastorno genético frecuente, especialmente en personas de ascendencia del norte de Europa.
  • La condición es frecuentemente mal diagnosticada, lo que lleva a un sobrediagnóstico en aquellos sin sobrecarga de hierro y a un subdiagnóstico en los individuos afectados.
  • Si no se trata, pueden surgir complicaciones graves, como cirrosis hepática, cáncer de hígado y mortalidad.

Objetivo Del Estudio

  • Para proporcionar una visión general actualizada de la hemocromatosis.
  • Para discutir la fisiopatología, la genética y la presentación clínica de la enfermedad.
  • Revisar las estrategias diagnósticas y terapéuticas, centrándose en la flebotomía.

Principales Métodos

  • Revisión de la literatura actual y de las directrices clínicas.
  • Análisis de las pruebas genéticas y criterios de diagnóstico.
  • Evaluación de los resultados terapéuticos y las direcciones futuras de la investigación.

Principales Resultados

  • Las pruebas genéticas permiten el diagnóstico precoz de la hemocromatosis.
  • La flebotomía periódica es un tratamiento eficaz para controlar la sobrecarga de hierro.
  • La intervención oportuna reduce significativamente el riesgo de complicaciones graves.

Conclusiones

  • El diagnóstico preciso a través de pruebas genéticas es crucial para una gestión eficaz.
  • La flebotomía sigue siendo la piedra angular del tratamiento de la hemocromatosis.
  • Se necesita una investigación continua para refinar el entendimiento y mejorar los resultados de los pacientes.

Videos de Conceptos Relacionados

Necrosis 01:16

4.7K

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...

Disorders of Erythrocytes 01:27

1.0K

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...

Cardiomyopathy III: Hypertrophic Cardiomyopathy 01:29

18

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

Cardiomyopathy IV: Restrictive Cardiomyopathy 01:29

13

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...

The Early Endosome: Endocytosis of Transferrin 01:28

3.4K

Essential proteins such as insulin or low-density lipoprotein (LDL) and micronutrients such as iron enter a eukaryotic cell through receptor-mediated endocytosis. Subsequently, the early endosomes fuse with the vesicles containing such receptor-ligand complexes and play a vital role in sorting the incoming ligands and receptors. While the ligands are either degraded inside the vesicle or released into the cytosol, their receptors are returned to the plasma membrane for further rounds of...

Diseases of the Liver and Gallbladder 01:26

759

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...